[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100573712":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":33,"centralContacts":48,"locations":57,"responsibleParty":90,"collaborators":92,"id":99,"slug":100,"hasResults":101,"nctId":102,"briefTitle":103,"officialTitle":104,"acronym":105,"eligibilityCriteria":106,"healthyVolunteers":107,"sex":108,"minAge":109,"maxAge":110,"enrollmentInfo":111,"targetDuration":23,"studyType":114,"phases":115,"briefSummary":117,"conditions":118,"keywords":120,"overallStatus":60,"whyStopped":23,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":129,"completionDateStruct":131,"leadSponsor":133,"locationsCount":134},{"fullName":5,"class":6},"International Agency for Research on Cancer","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Outreach","EXPERIMENTAL","Women receive invitation letter with HPV self-sampling kit; Direct mailing of HPV self-sampling kit; Women receive HPV self-sampling kit with instructions; SMS reminder at 3 months if no participation; Assistance provided for triage cytology if HPV positive.",[13],"Other: Women receive invitation letter with HPV self-sampling kit",{"label":15,"type":10,"description":16,"interventionNames":17},"Choice","Women receive an invitation letter offering a choice between ordering a free self-sampling kit or visiting a healthcare provider.\n\nOption between self-sampling and healthcare provider: women can choose testing method. If self-sampling chosen, kit sent to home. SMS reminder at 3 months if no participation.",[18],"Other: Women receive invitation letter with choice of ordering a free self-sampling kit or visit healthcare provider",{"label":20,"type":21,"description":22,"interventionNames":23},"Control arm","NO_INTERVENTION","Standard invitation to visit healthcare provider for cervical cancer screening. Standard screening procedure. Follow standard organized screening program procedure. HPV self-sampling offered at 12-month reminder if no participation.",null,[25,29],{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":23},"Women receive invitation letter with HPV self-sampling kit","Direct mailing of HPV self-sampling kit. Women receive HPV self-sampling kit with instructions. SMS reminder at 3 months if no participation. Assistance provided for triage cytology if HPV positive.",[9],{"type":6,"name":30,"description":31,"armGroupLabels":32,"otherNames":23},"Women receive invitation letter with choice of ordering a free self-sampling kit or visit healthcare provider","Option between self-sampling and healthcare provider: women can choose testing method. If self-sampling chosen, kit sent to home. SMS reminder at 3 months if no participation.",[15],[34,38,41,44,46],{"name":35,"affiliation":36,"role":37},"Aurélie BERTRAND-BRICE, MD","Regional Cancer Screening Coordinating Centre, Marne site","PRINCIPAL_INVESTIGATOR",{"name":39,"affiliation":40,"role":37},"Christine CLAVEL CRAVOISIER, Professor","CHU de Reims",{"name":42,"affiliation":43,"role":37},"Hamza ACHIT, PhD","CHRU Nancy",{"name":45,"affiliation":5,"role":37},"Farida SELMOUNI, PhD",{"name":47,"affiliation":5,"role":37},"Catherine SAUVAGET, MD, PhD",[49,54],{"name":50,"role":51,"phone":52,"phoneExt":23,"email":53},"Farida Selmouni, PhD","CONTACT","+33 4 72738485","selmounif@iarc.who.int",{"name":55,"role":51,"phone":52,"phoneExt":23,"email":56},"Catherine Sauvaget, MD, PhD","sauvagetc@iarc.who.int",[58,77],{"facility":59,"status":60,"city":61,"state":62,"zip":63,"country":64,"countryCode":65,"cosmosGeoPoint":66,"geoPoint":71,"contacts":72},"Regional Cancer Screening Coordinating Centre, Aube site","RECRUITING","Troyes","Aube","10000","France","FR",{"type":67,"coordinates":68},"Point",[69,70],4.08524,48.30073,{"lat":70,"lon":69},[73],{"name":74,"role":51,"phone":75,"phoneExt":23,"email":76},"Lucie FIEVET, MD","03-26-84-93-31","l.fievet@depistagecancer-ge.fr",{"facility":36,"status":60,"city":78,"state":79,"zip":80,"country":64,"countryCode":65,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"Reims","Marne","51100",{"type":67,"coordinates":82},[83,84],4.02853,49.26526,{"lat":84,"lon":83},[87],{"name":35,"role":51,"phone":88,"phoneExt":23,"email":89},"03-25-41-62-87","a.bertrand@depistagecancer-ge.fr",{"type":91,"investigatorFullName":23,"investigatorTitle":23,"investigatorAffiliation":23,"oldNameTitle":23,"oldOrganization":23},"SPONSOR",[93,96,98],{"name":94,"class":95},"National Cancer Institute, France","OTHER_GOV",{"name":97,"class":6},"Central Hospital, Nancy, France",{"name":40,"class":6},"100573712","hpv-self-sampling-in-the-general-population-100573712",false,"NCT06749847","HPV Self-sampling in the General Population","HPV Self-sampling in the General Population: Efficacy, Feasibility, Acceptability and Cost-effectiveness","MIRABELLE","Inclusion Criteria:\n\n* Women aged 30 to 65 years old\n* Living in the study area (Departments of Marne and Aube, France)\n* At moderate risk of cervical cancer, i.e. eligible to the organised programme and receiving the first invitation of the screening round (not a reminder letter)\n\nExclusion Criteria:\n\n* Outside the target age (less than 30 years old, or 66 years old and more)\n* Already participating in the current screening round\n* Total hysterectomy\n* History of cervical cancer\n* Current follow-up for abnormal cervical screening result or cervical lesions",true,"FEMALE","30 Years","65 Years",{"count":112,"type":113},6000,"ESTIMATED","INTERVENTIONAL",[116],"NA","A randomized controlled trial comparing three strategies for cervical cancer screening: direct mailing of HPV self-sampling kit (\"Outreach\" arm), choice between self-sampling or healthcare provider sampling (\"Choice\" arm), and standard care (control arm) in two French departments.",[119],"Cervical Cancer",[121,122,123,124,64],"Cervical cancer","screening program","pilot project","randomised control trial","2025-07-22",{"date":127,"type":128},"2025-07-23","ACTUAL",{"date":130,"type":128},"2025-06-26",{"date":132,"type":113},"2026-12-31",{"name":5,"class":6},2]